The MarketReader Minute
π IBB Rises as Trump Election Boosts Biotech Sector Outlook; EXAS Drops After Missed Q3 Earnings and Guidance Cut | Biotech Sector Insights
(IBB) has seen a price increase of 0.4% since Tuesday. Analysts at BMO Capital Markets anticipate a modest positive impact on the biopharma sector following Donald Trump's victory in the U.S. presidential election.